Abequolixron (RGX-104) and Durvalumab in Lung Cancer
Clinical trial NCT05911308 · TERMINATED
Trial details
- NCT number
- NCT05911308
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-10-04
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.